heat News and Research

RSS

CDP commends Pfizer for addressing climate change practices

Pfizer Inc has been commended by the Carbon Disclosure Project (CDP) for its approach to addressing climate change. CDP named Pfizer to its Climate Disclosure Leadership Index, which highlights the company’s climate change disclosure practices. This is the third consecutive year that Pfizer has been recognized by CDP.

22 Sep 2009

Study reveals effectiveness of targeted heat therapy in addition to chemotherapy

Patients with soft-tissue sarcomas at high risk of spreading were 30% more likely to be alive and cancer free almost three years after starting treatment if their tumours were heated at the time they received chemotherapy, according to new research. The finding bolsters the case for intensifying exploration of the strategy in other types of cancer.

22 Sep 2009

Small business operators worried over proposed health care legislation

The U.S. Congress is back in session with Health Care legislation dominating the attention of lawmakers and the public. The current proposed health care legislation will mandate small business with payrolls more than $250,000 to provide health insurance to their workers or pay a fine.

22 Sep 2009

Biochemists are developing a new system to better understand antibiotic resistance

Rice University biochemists are developing a system of "evolutionary forecasting" to better understand the mechanisms of antibiotic resistance.

22 Sep 2009

Celsion recommended to continue patient enrollment in its ThermoDox Phase III liver cancer trial

Celsion Corporation (NASDAQ:CLSN) announced today the Data Safety Monitoring Board (“DSMB”) has reviewed the safety data from the first group of patients enrolled in its pivotal ThermoDox® Phase III clinical trial for primary liver cancer (“HEAT study”) and has recommended that Celsion continue to enroll patients in the trial.

21 Sep 2009

NIAID awards DOR BioPharma a $9M grant to develop thermostable and rapidly acting vaccines

DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biotechnology company, announced today that it has been awarded an approximate $9.4 Million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH).

21 Sep 2009

Praxair China installs NCOOL system at Shanghai Pharmaceutical

Praxair China has installed its NCOOL™ cryogenic heat exchanger system at Shanghai The First Biochemical & Pharmaceutical Co., Ltd., an affiliate of Shanghai Pharmaceutical (Group) Ltd. This is the first liquid nitrogen supply contract that Praxair China has signed that employs Praxair’s patented NCOOL cryogenic heat exchanger system in a pharmaceutical freeze dryer.

21 Sep 2009

Research combining magnetism and nanotechnology

Researchers led by Daniel Kohane, MD, PhD of Children's Hospital Boston, funded by the National Institutes of Health, have devised a solution that combines magnetism with nanotechnology.

21 Sep 2009

Nutrient-rich powder from wine by-products

Two years ago, a group of friends were enjoying a glass of wine in the Mosel region in south-west Germany when their conversation turned to the health benefits which studies attribute to the drink.

18 Sep 2009

Merck, Wellcome Trust to launch vaccine center in India to produce vaccines for developing countries

Pharmaceutical company Merck and the Wellcome Trust have joined together to create a non-profit, £90-million (about $150 million) research center in India to facilitate the development of new vaccines, "including [those for] neglected diseases for which inadequate or no vaccines exist," Nature News reports.

18 Sep 2009

Study focuses on hypertension

How high blood pressure develops and the effects it has on the body are the focus of a two-part study underway at Penn State and Johns Hopkins University that will look at hypertension in the human body and in the laboratory.

17 Sep 2009

First Edition: September 16, 2009

Today's biggest story -- Senate Finance Committee Chair Max Baucus, D-Mont., will unveil his health reform proposals. Who will support it? And won't?

16 Sep 2009

Laser technology lowers manufacturing cost of artificial joints and arterial stents

Researchers are developing technologies that use lasers to create arterial stents and longer-lasting medical implants that could be manufactured 10 times faster and also less expensively than is now possible.

16 Sep 2009

Pilkington receives license to produce SPD-SmartGlass panels

Today at the Frankfurt International Motor Show, Pilkington Group Limited announced that it has acquired a new license from Research Frontiers Inc. to offer SPD-Smart automotive end-products globally.

16 Sep 2009

Zhena's Gypsy Tea launches campaign for breast cancer awareness and prevention

Zhena's Gypsy Tea, the innovative tea company, turns up the heat on the battle against breast cancer with its campaign dedicated to urging awareness, preventing breast cancer and finding a cure. Spearheaded by the slogan; Drink Pink-Think Pink, a 70 cent donation of each sale of a the company's popular PINK SUPERBERRY TEA for Women's Health will go directly to The Breast Cancer Research Foundation(R) (BCRF), in support of finding a cure and funding clinical and genetic research worldwide.

15 Sep 2009

On '60 Minutes,' Obama says he is responsible for health legislation: 'I own it'

President Barack Obama Sunday night in an appearance on CBS' 60 Minutes said that some Republicans just want to "kill" health care reform and that he'll "own" the bill when it passes.

14 Sep 2009

Tips from ADT to prevent carbon monoxide poisoning

As Americans in many parts of the country gear up for colder weather, others brace for the peak of hurricane season. This means more families will begin using fuel-burning space heaters and portable generators that may release harmful carbon monoxide (CO) gas.

14 Sep 2009

ALF, Celsion partner to educate physicians about primary liver cancer treatments

Celsion Corporation (NASDAQ:CLSN) and the American Liver Foundation (ALF) announced today that they have formed a partnership to provide education to physicians and liver patients about the treatment options for hepatocellular carcinoma (commonly referred to as primary liver cancer) and Celsion’s on-going ThermoDox Phase III global HEAT clinical study.

14 Sep 2009

RAD LPX display controller boards from Matrox Graphics

Matrox Graphics Inc., the leading manufacturer of specialized graphics solutions, is pleased to announce the introduction of the new "Low Power, Low Profile, eXtended function" RAD LPX Series display controller boards for space, budget and energy sensitive healthcare enterprises and medical imaging professionals.

10 Sep 2009

Nanotubes destroy kidney tumors

By injecting multiwalled carbon nanotubes (MWCNTs) into tumors and heating them with a quick, 30-second zap of a laser, a multi-institutional team of researchers from the Wake Forest University School of Medicine (WFUSOM), Wake Forest University Center for Nanotechnology and Molecular Materials, Rice University, and Virginia Polytechnic Institute and State University has developed a new type of therapy that effectively kills kidney tumors in nearly 80% of treated mice. Researchers say that the findings, which were published in the Proceedings of the National Academy of Sciences of the United States of America, suggest a potential future cancer treatment for humans.

7 Sep 2009

heat News and Research

CDP commends Pfizer for addressing climate change practices

Study reveals effectiveness of targeted heat therapy in addition to chemotherapy

Small business operators worried over proposed health care legislation

Biochemists are developing a new system to better understand antibiotic resistance

Celsion recommended to continue patient enrollment in its ThermoDox Phase III liver cancer trial

NIAID awards DOR BioPharma a $9M grant to develop thermostable and rapidly acting vaccines

Praxair China installs NCOOL system at Shanghai Pharmaceutical

Research combining magnetism and nanotechnology

Nutrient-rich powder from wine by-products

Merck, Wellcome Trust to launch vaccine center in India to produce vaccines for developing countries

Study focuses on hypertension

First Edition: September 16, 2009

Laser technology lowers manufacturing cost of artificial joints and arterial stents

Pilkington receives license to produce SPD-SmartGlass panels

Zhena's Gypsy Tea launches campaign for breast cancer awareness and prevention

On '60 Minutes,' Obama says he is responsible for health legislation: 'I own it'

Tips from ADT to prevent carbon monoxide poisoning

ALF, Celsion partner to educate physicians about primary liver cancer treatments

RAD LPX display controller boards from Matrox Graphics

Nanotubes destroy kidney tumors

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News